{"0": ["cost", "could", "seen", "obstacle", "patients", "considering", "prolia", "treatment", "option", "generic", "fosamax", "costs", "roughly", "per", "year", "brand-name", "bisphosphonates", "slightly", "less", "1,000", "per", "year", "prolia", "cost", "1,650", "per", "year", "plus", "cost", "associated", "office", "visit", "prolia", "also", "expensive", "reclast", "costs", "1,100", "yearly", "dose"], "1": ["healthcare", "providers", "involved", "fight", "osteoporosis", "one", "weapon", "arsenal", "fda", "recently", "approved", "sale", "prolia", "denosumab", "twice-yearly", "injection", "indicated", "postmenopausal", "women"], "2": ["denosumab", "prolia", "\u00ae", "bisphosphonate", "monoclonal", "antibody", "inhibits", "bone", "resorption", "mechanisms", "different", "bisphosphonates", "see", "previous", "newsletter", "executive", "summary", "report", "addressed", "issues", "serum", "ctx", "tests", "drug", "holidays"], "3": ["like", "bisphosphonates", "denosumab", "trade", "names", "prolia", "xgeva", "also", "prevents", "osteoclasts", "removing", "old", "damaged", "worn", "bone", "different", "action", "bisphosphonates", "\u2014", "action", "may", "turn", "even", "harmful", "side-effects", "instead", "poisoning", "already", "mature", "osteoclasts", "bisphosphonates", "denosumab", "prevents", "precursor", "cells", "osteoclasts", "ever", "developing", "osteoclasts"], "4": ["pros", "prolia", "works", "equally", "well", "types", "fractures", "hip", "vertebral", "avoid", "gastrointestinal", "issues", "common", "bisphosphonates", "taken", "twice", "year", "cons", "advised", "postmenopausal", "women", "increased", "risk", "bone", "fracture"], "5": ["denosumab", "prolia", "newer", "medication", "shown", "reduce", "risk", "osteoporotic", "fracture", "women", "men", "unrelated", "bisphosphonates", "denosumab", "might", "used", "people", "can't", "take", "bisphosphonate", "people", "reduced", "kidney", "function"], "6": ["like", "bisphosphonates", "prolia", "focuses", "osteoclasts", "cells", "break", "bones", "causing", "shed", "lose", "density", "different", "way", "targeting", "protein", "called", "rank", "ligand", "controls", "activity", "osteoclasts"], "7": ["expected", "prior", "studies", "denosumab", "however", "cause", "number", "adverse", "effects", "men", "including", "hypocalcemia", "1.7", "versus", "0.3", "placebo", "well", "rate", "osteonecrosis", "jaw", "occur", "control", "group"]}